Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

Japan Flavour and Fragrance Materials Association's (JFFMA) safety assessment of food-flavouring substances uniquely used in Japan that belong to the class of aliphatic primary alcohols, aldehydes, carboxylic acids, acetals and esters containing additional oxygenated functional groups.

Saito K, Hasegawa-Baba Y, Sekiya F, Hayashi SM, Mirokuji Y, Okamura H, Maruyama S, Ono A, Nakajima M, Degawa M, Ozawa S, Shibutani M, Maitani T.

Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2017 Sep;34(9):1474-1484. doi: 10.1080/19440049.2017.1333160. Epub 2017 Jul 19.

PMID:
28540764
2.

Safety and efficacy of the leukocytapheresis procedure in eighty-five patients with rheumatoid arthritis.

Kitagaichi M, Kusaoi M, Tsukahara T, Murayama G, Nemoto T, Sekiya F, Kon T, Ogasawara M, Kempe K, Yamaji K, Tamura N, Tsuda H, Takasaki Y.

Transfus Apher Sci. 2016 Oct;55(2):225-232. doi: 10.1016/j.transci.2016.07.019. Epub 2016 Jul 21.

PMID:
27475801
3.

Separation of Circulating MicroRNAs Using Apheresis in Patients With Systemic Lupus Erythematosus.

Kusaoi M, Yamaji K, Ishibe Y, Murayama G, Nemoto T, Sekiya F, Kon T, Ogasawara M, Kempe K, Tamura N, Takasaki Y.

Ther Apher Dial. 2016 Aug;20(4):348-53. doi: 10.1111/1744-9987.12471.

PMID:
27523074
4.

Involvement of Mucosal-associated Invariant T cells in Ankylosing Spondylitis.

Hayashi E, Chiba A, Tada K, Haga K, Kitagaichi M, Nakajima S, Kusaoi M, Sekiya F, Ogasawara M, Yamaji K, Tamura N, Takasaki Y, Miyake S.

J Rheumatol. 2016 Sep;43(9):1695-703. doi: 10.3899/jrheum.151133. Epub 2016 Jul 1.

PMID:
27370879
5.

The Japan Flavour and Fragrance Materials Association's (JFFMA) safety assessment of acetal food flavouring substances uniquely used in Japan.

Okamura H, Abe H, Hasegawa-Baba Y, Saito K, Sekiya F, Hayashi SM, Mirokuji Y, Maruyama S, Ono A, Nakajima M, Degawa M, Ozawa S, Shibutani M, Maitani T.

Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2015;32(9):1384-96. doi: 10.1080/19440049.2015.1067927. Epub 2015 Aug 14. Review.

PMID:
26212670
6.

The JFFMA assessment of flavoring substances structurally related to menthol and uniquely used in Japan.

Mirokuji Y, Abe H, Okamura H, Saito K, Sekiya F, Hayashi SM, Maruyama S, Ono A, Nakajima M, Degawa M, Ozawa S, Shibutani M, Maitani T.

Food Chem Toxicol. 2014 Feb;64:314-21. doi: 10.1016/j.fct.2013.11.044. Epub 2013 Dec 2. Review.

PMID:
24309148
7.

Reduction in bradykinin generation during leukocytapheresis using novel cellsorba(TM) CS-180S: Effects of changing the filling solution.

Yamada R, Kusaoi M, Murayama G, Yasui M, Hishinuma R, Nemoto T, Hohtatsu K, Kageyama M, Kawamoto T, Sugimoto K, Sekiya F, Kon T, Ogasawara M, Kempe K, Yamaji K, Tsuda H, Takasaki Y.

J Clin Apher. 2014 Apr;29(2):90-6. doi: 10.1002/jca.21297. Epub 2013 Sep 11.

PMID:
24023037
8.

Gene expression analysis using a high-resolution DNA microarray of peripheral whole blood immediately before and after leukocytapheresis for rheumatoid arthritis.

Kusaoi M, Yamaji K, Murayama G, Yasui M, Yamada R, Hishinuma R, Nemoto T, Hohtatsu K, Kageyama M, Kawamoto T, Sugimoto K, Sekiya F, Kon T, Ogasawara M, Kempe K, Tsuda H, Takasaki Y.

Ther Apher Dial. 2012 Oct;16(5):456-66. doi: 10.1111/j.1744-9987.2012.01111.x.

PMID:
23046371
9.

Autofeedback from ultrasound images provides rapid improvement in palpation skills for identifying joint swelling in rheumatoid arthritis.

Ogasawara M, Murayama G, Yamada Y, Nemoto T, Kageyama M, Toyama S, Kusaoi M, Onuma S, Kon T, Sekiya F, Sugimoto K, Matsudaira R, Matsushita M, Tada K, Kempe K, Yamaji K, Tamura N, Takasaki Y.

J Rheumatol. 2012 Jun;39(6):1207-14. doi: 10.3899/jrheum.111433. Epub 2012 May 15. Erratum in: J Rheumatol. 2012 Sep;39(9):1908.

PMID:
22589253
10.

Recent trends in use of nonbiologic DMARDs and evaluation of their continuation rates in single and dual combination therapies in rheumatoid arthritis patients in Japan.

Ogasawara M, Kageyama M, Kusaoi M, Onuma S, Kon T, Sekiya F, Sugimoto K, Matsudaira R, Matsushita M, Tada K, Kempe K, Yamaji K, Tamura N, Takasaki Y.

Mod Rheumatol. 2012 Nov;22(6):831-6. doi: 10.1007/s10165-012-0606-0. Epub 2012 Feb 17.

PMID:
22350576
11.

Anti-Ro/SSA antibodies are an independent factor associated with an insufficient response to tumor necrosis factor inhibitors in patients with rheumatoid arthritis.

Matsudaira R, Tamura N, Sekiya F, Ogasawara M, Yamanaka K, Takasaki Y.

J Rheumatol. 2011 Nov;38(11):2346-54. doi: 10.3899/jrheum.101295. Epub 2011 Oct 1.

PMID:
21965648
12.

Effect of various anticoagulant agents on large-volume leukocytapheresis using new Cellsorba CS-180S Filter.

Hohtatsu K, Yamaji K, Yamada R, Oda K, Kageyama M, Kusaoi M, Onuma S, Kawamoto T, Sugimoto K, Sekiya F, Kon T, Ogasawara M, Kempe K, Tsuda H, Takasaki Y.

Ther Apher Dial. 2011 Aug;15(4):355-9. doi: 10.1111/j.1744-9987.2011.00962.x.

PMID:
21884469
13.

Single-center, retrospective analysis of efficacy and safety of tacrolimus as a second-line DMARD in combination therapy and the risk factors contributing to adverse events in 115 patients with rheumatoid arthritis.

Ogasawara M, Tamura N, Kageyama M, Onuma S, Kusaoi M, Toyama S, Sekiya F, Matsudaira R, Nawata M, Tada K, Matsushita M, Kempe K, Amano H, Morimoto S, Yamaji K, Takasaki Y.

Clin Rheumatol. 2012 Feb;31(2):251-7. doi: 10.1007/s10067-011-1810-6. Epub 2011 Jul 20.

PMID:
21773713
14.

Observational cross-sectional study revealing less aggressive treatment in Japanese elderly than nonelderly patients with rheumatoid arthritis.

Ogasawara M, Tamura N, Onuma S, Kusaoi M, Sekiya F, Matsudaira R, Kempe K, Yamaji K, Takasaki Y.

J Clin Rheumatol. 2010 Dec;16(8):370-4. doi: 10.1097/RHU.0b013e3181fe8b37.

PMID:
21085019
15.

Investigation of occurrence of osteonecrosis of the femoral head after increasing corticosteroids in patients with recurring systemic lupus erythematosus.

Sekiya F, Yamaji K, Yang K, Tsuda H, Takasaki Y.

Rheumatol Int. 2010 Nov;30(12):1587-93. doi: 10.1007/s00296-009-1194-y. Epub 2009 Oct 7.

PMID:
19809818
16.

Intramolecular interaction between phosphorylated tyrosine-783 and the C-terminal Src homology 2 domain activates phospholipase C-gamma1.

Poulin B, Sekiya F, Rhee SG.

Proc Natl Acad Sci U S A. 2005 Mar 22;102(12):4276-81. Epub 2005 Mar 11.

17.

Mechanism of B-cell receptor-induced phosphorylation and activation of phospholipase C-gamma2.

Kim YJ, Sekiya F, Poulin B, Bae YS, Rhee SG.

Mol Cell Biol. 2004 Nov;24(22):9986-99.

18.

Identification of phospholipase C-gamma1 as a mitogen-activated protein kinase substrate.

Buckley CT, Sekiya F, Kim YJ, Rhee SG, Caldwell KK.

J Biol Chem. 2004 Oct 1;279(40):41807-14. Epub 2004 Jul 16.

19.
20.

Glycoproteins VI and Ib-IX-V stimulate tyrosine phosphorylation of tyrosine kinase Syk and phospholipase Cgamma2 at distinct sites.

Suzuki-Inoue K, Wilde JI, Andrews RK, Auger JM, Siraganian RP, Sekiya F, Rhee SG, Watson SP.

Biochem J. 2004 Mar 15;378(Pt 3):1023-9.

23.

Regulation of phospholipase C isozymes: activation of phospholipase C-gamma in the absence of tyrosine-phosphorylation.

Sekiya F, Bae YS, Rhee SG.

Chem Phys Lipids. 1999 Apr;98(1-2):3-11. Review.

PMID:
10358923
24.

AHNAK, a protein that binds and activates phospholipase C-gamma1 in the presence of arachidonic acid.

Sekiya F, Bae YS, Jhon DY, Hwang SC, Rhee SG.

J Biol Chem. 1999 May 14;274(20):13900-7.

25.

Prothrombin and factor X activator activities in the venoms of Viperidae snakes.

Yamada D, Sekiya F, Morita T.

Toxicon. 1997 Nov;35(11):1581-9.

PMID:
9428105
26.

Inhibition of phospholipase D by clathrin assembly protein 3 (AP3).

Lee C, Kang HS, Chung JK, Sekiya F, Kim JR, Han JS, Kim SR, Bae YS, Morris AJ, Rhee SG.

J Biol Chem. 1997 Jun 20;272(25):15986-92.

27.

Synaptojanin inhibition of phospholipase D activity by hydrolysis of phosphatidylinositol 4,5-bisphosphate.

Chung JK, Sekiya F, Kang HS, Lee C, Han JS, Kim SR, Bae YS, Morris AJ, Rhee SG.

J Biol Chem. 1997 Jun 20;272(25):15980-5.

28.

Localization of the specific binding site for magnesium(II) ions in factor IX.

Sekiya F, Yoshida M, Yamashita T, Morita T.

FEBS Lett. 1996 Sep 2;392(3):205-8.

29.
31.

Structure and functions of coagulation factor IX/factor X-binding protein isolated from the venom of Trimeresurus flavoviridis.

Morita T, Atoda H, Sekiya F.

Adv Exp Med Biol. 1996;391:187-96. Review. No abstract available.

PMID:
8726056
32.

Blood coagulation factor IX-binding protein from the venom of Trimeresurus flavoviridis: purification and characterization.

Atoda H, Ishikawa M, Yoshihara E, Sekiya F, Morita T.

J Biochem. 1995 Nov;118(5):965-73.

33.
34.

Regulation of the tertiary structure and function of coagulation factor IX by magnesium (II) ions.

Sekiya F, Yamashita T, Atoda H, Komiyama Y, Morita T.

J Biol Chem. 1995 Jun 16;270(24):14325-31.

35.
36.
37.

Activation of phospholipases in platelets by polyclonal antibodies against a surface membrane protein.

Hashimoto K, Sekiya F, Takagi J, Tsukada T, Sato F, Saito Y.

Biochim Biophys Acta. 1992 Nov 11;1165(1):27-31.

PMID:
1420344
38.

12S-hydroxyeicosatetraenoic acid plays a central role in the regulation of platelet activation.

Sekiya F, Takagi J, Usui T, Kawajiri K, Kobayashi Y, Sato F, Saito Y.

Biochem Biophys Res Commun. 1991 Aug 30;179(1):345-51.

PMID:
1652954
39.

Immunological detection of propolypeptide of von Willebrand factor on platelet surface.

Hashimoto K, Usui T, Sasaki K, Fujisawa T, Sekiya F, Takagi J, Tsukada T, Saito Y.

Biochem Biophys Res Commun. 1991 May 15;176(3):1571-6.

PMID:
2039531
40.

Monoclonal antibodies that inhibit binding of propolypeptide of von Willebrand factor to collagen. Localization of epitopes.

Fujisawa T, Takagi J, Sekiya F, Goto A, Miake F, Saito Y.

Eur J Biochem. 1991 Mar 28;196(3):673-7.

41.

Collagen-binding domain within bovine propolypeptide of von Willebrand factor.

Takagi J, Fujisawa T, Sekiya F, Saito Y.

J Biol Chem. 1991 Mar 25;266(9):5575-9.

42.

Metabolism of 3-deoxyglucosone, an intermediate compound in the Maillard reaction, administered orally or intravenously to rats.

Kato H, van Chuyen N, Shinoda T, Sekiya F, Hayase F.

Biochim Biophys Acta. 1990 Jul 20;1035(1):71-6.

PMID:
2383581
43.

Cooperativity between platelet-activating factor and collagen in aggregation of bovine platelets III.

Kojima S, Sekiya F, Inada Y, Sato F, Tsukada T, Saito Y.

FEBS Lett. 1990 Jul 16;267(2):226-8.

44.

Albumin in plasma potentiates platelet aggregation induced by collagen--a study with an albumin deficient rat.

Sekiya F, Kawajiri K, Takagi J, Saito Y, Nagase S.

Thromb Res. 1990 Jun 15;58(6):657-62. No abstract available.

PMID:
2117307
45.

Cooperativity between platelet-activating factor and collagen in aggregation of bovine platelets, II.

Kojima S, Sekiya F, Inada Y, Tsukada T, Saito Y.

Biochem Biophys Res Commun. 1990 May 16;168(3):1292-6.

PMID:
2346486
46.

Feedback regulation of platelet function by 12S-hydroxyeicosatetraenoic acid: inhibition of arachidonic acid liberation from phospholipids.

Sekiya F, Takagi J, Sasaki K, Kawajiri K, Kobayashi Y, Sato F, Saito Y.

Biochim Biophys Acta. 1990 May 1;1044(1):165-8.

PMID:
2111172
47.

Elucidation of a role of plasma albumin during collagen-induced aggregation of bovine platelets.

Sekiya F, Takagi J, Saito Y.

Thromb Res. 1989 Nov 1;56(3):407-15.

PMID:
2515611
48.

A collagen-binding glycoprotein from bovine platelets is identical to propolypeptide of von Willebrand factor.

Takagi J, Kasahara K, Sekiya F, Inada Y, Saito Y.

J Biol Chem. 1989 Jun 25;264(18):10425-30.

49.

Inhibition of platelet-collagen interaction by propolypeptide of von Willebrand factor.

Takagi J, Sekiya F, Kasahara K, Inada Y, Saito Y.

J Biol Chem. 1989 Apr 15;264(11):6017-20.

50.

Plasma albumin is essential for collagen-induced platelet aggregation.

Sekiya F, Takagi J, Kasahara K, Inada Y, Saito Y.

Thromb Res. 1988 Jun 15;50(6):837-46.

PMID:
3046043

Supplemental Content

Loading ...
Support Center